Story · Medicine & Biotech
Georgina Long: INTerpath-001 mRNA Vaccine Improves Recurrence-Free Survival in High-Risk Melanoma
1 outlet · first reported by OncoDaily on
Georgina Long, Medical Director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research at the University of Sydney, shared on X: “I am delighted to share (OncoDaily)
Coverage, in order
-
Georgina Long: INTerpath-001 mRNA Vaccine Improves Recurrence-Free Survival in High-Risk MelanomaGeorgina Long, Medical Director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research at the University of Sydney, shared on X: “I am delighted to share
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.